Mount Yale Investment Advisors, LLC Vaxcyte, Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.03 Billion
- Q3 2024
A detailed history of Mount Yale Investment Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 4,000 shares of PCVX stock, worth $424,560. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,971
19.53%
Holding current value
$424,560
Previous $375,000
21.6%
% of portfolio
0.04%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding PCVX
# of Institutions
289Shares Held
110MCall Options Held
246KPut Options Held
98.7K-
Black Rock Inc. New York, NY9.94MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.04 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$941 Million0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$871 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$488 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.3B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...